Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GNVC

GenVec (GNVC) Stock Price, News & Analysis

GenVec logo

About GenVec Stock (NASDAQ:GNVC)

Advanced Chart

Key Stats

Today's Range
$7.19
$7.19
50-Day Range
N/A
52-Week Range
$2.70
$10.44
Volume
N/A
Average Volume
259,136 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GenVec and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GNVC Stock News Headlines

Cold virus can hunt down cancer
Huangshan Novel Co Ltd Class A 002014
Turn $1K into $50K with This DeFi Gem
Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.tc pixel
GenVec Stock Hit by Pancreas Study's Details
Early Volume Plays: Novavax, GenVec
GenVec Value Slammed on Drug Failure
See More Headlines

GNVC Stock Analysis - Frequently Asked Questions

GenVec Inc (NASDAQ:GNVC) announced its earnings results on Friday, November, 4th. The biopharmaceutical company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The biopharmaceutical company earned $0.17 million during the quarter, compared to analyst estimates of $0.07 million.

Shares of GenVec reverse split on the morning of Thursday, December 1st 2016.The 1-10 reverse split was announced on Wednesday, November 16th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 30th 2016. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that GenVec investors own include Meta Platforms (META), Sarepta Therapeutics (SRPT), Alibaba Group (BABA), NVE (NVEC), Microbot Medical (MBOT) and Pluristem Therapeutics (PSTI).

Company Calendar

Last Earnings
11/04/2016
Today
9/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:GNVC
CIK
934473
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GNVC) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners